CWM
JAZZ icon

Cordatus Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cordatus Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,855
Closed -$228K – 64
2023
Q4 		$228K Sell
1,855
-38
-2% -$4.74K 0.19% 53
2023
Q3 		$245K Sell
1,893
-37
-2% -$4.93K 0.22% 50
2023
Q2 		$239K Buy
+1,930
New +$260K 0.09% 139
2022
Q3 		– Sell
-7,325
Closed -$1.14M – 109
2022
Q2 		$1.14M Sell
7,325
-474
-6% -$73K 0.53% 74
2022
Q1 		$1.21M Buy
+7,799
New +$1.13M 0.43% 90

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cordatus Wealth Management's JAZZ Position: Q1 2024 in Review

Cordatus Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 1,855 shares — an estimated $228K sold.

Cordatus Wealth Management first reported a position in JAZZ in Q1 2022 and held it in 5 quarters. The position peaked at $1.21M in Q1 2022. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Cordatus Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cordatus Wealth Management sold 1,855 Jazz Pharmaceuticals shares in Q1 2024, an estimated $228K.
  • Cordatus Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2022 and held it in 5 quarters.
  • Cordatus Wealth Management's Jazz Pharmaceuticals position peaked at $1.21M in Q1 2022.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Cordatus Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.